full list rate price target
earn report pleas see tabl
initi coverag dialysi
initi coverag six stock dialysi post-acut sub-sector
within broader sector
dialysi patient volum grow per year medicar price outlook
better five year game chang coordin care legisl
continu gain momentum congress
like risk/reward head overweight given
industri backdrop expect materi accret share repurchas
next year follow sale davita medic group dmg pro-forma
dmg sale share trade signific discount histor
trade rang yet see return growth addit
avenu acceler longer term growth form coordin care
platform exclus focuss joint ventur partnership nephrologist
see de novo jv model drive treatment growth around ara smaller
base clinic next year expect recent slowdown de novo
ramp persist howev weigh ebitda growth
post-acut care industri undergo transform evolut toward
home health set industri head long
term expect home health provid continu captur market share
higher cost set skill nurs facil expect scale player
continu market consolid current valuat believ opportun
price lhc group equal weight
encompass health equal weight lead inpati rehabilit
facil irf platform industri smaller fast-grow home health
platform continu benefit develop program share
fulli discount opportun present
select medic equal weight irf platform produc strong growth via
jv strategi lead health system fast-grow irf segment
revenu howev view major busi segment
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
summari rate price target earn estim report
barclay research share price target price shown primari list currenc ep estim shown report currenc
current fiscal year estim barclay research fiscal year estim barclay research
initi coverag us dialysi provid post-acut
initi coverag us dialysi provid post-acut
initi coverag six stock dialysi post-acut sub-sector within
broader sector
dialysi patient volum steadili grow per year high visibl rariti
healthcar provid univers lead caus end-stag renal diseas diabet
cdc forecast grow preval next decad
current cure end-stag renal diseas patient requir either life-sav dialysi
treatment kidney transplant surviv
medicar rate outlook better five year rate set increas
coordin care arrang medicar patient also offer potenti
long-term growth acceler develop would allow dialysi provid
manag entireti patient healthcar cost coordin integr
model repres materi revenu opportun industri
see ow pois share price rebound fuel sale dmg
substanti share repo well return normal oper incom growth
dialysi stock larg rang bound past three year industri
work commerci mix pressur continu believ caution
commerci mix warrant believ current share price over-discount
risk pressur
pro-forma dmg sale share trade signific discount
histor trade rang ebitda-nci estim yet see
return normal growth improv medicar price reduct
lobbi spend follow ballot initi modest commerci mix
pressur materi avenu growth longer term still intact form
focuss joint ventur partnership nephrologist ara oper structur
provid altern physician larg dialysi organ domin
dialysi market creat competit advantag recruit new partner denovo
clinic law larg number result slow top-lin growth expect
compani continu add clinic per year next sever year help
drive annual treatment growth vs treatment growth overal
industri sign deal denovo clinic pipelin
pipelin remain strong compani experienc increas time
get new clinic construct approv profit reason cite longer
histor ramp period denovo clinic includ tighter construct market
longer lead time get clinic built backlog get certif new
clinic anticip backlog larg mitig next year accept
third parti certif new clinic longer construct ramp time still
like persist first half
addit ara newli sign three-year contract unitedhealthcar effect
creat opportun increas commerci volum price reduct
bring unit network still headwind ebitda
post-acut care industri undergo transform evolut toward risk-
time rapid growth popul popul
particular like drive increas demand servic accord us censu
bureau us popul expect grow nearli next decad
compound-annual-growth-rate vs compound-annual-growth-rate babi boom gener age
popul util significantli care across healthcar continuum even
year-old popul health util rate three time higher
year-old popul hospic util nearli seven time higher
landscap chang payment model risk base contract increas demand
age boomer
increas consolid referr sourc local hospit
consolid post-acut provid increasingli need drive scale effici
analytical/data expertis provid deliv valu referr partner
system larg provid evid valu ultim benefit
view home health set industri move long-
term expect scale home health provid continu captur market share
higher cost set skill nurs facil continu consolid market
via acquisit howev current valuat believ opportun price
ew ew
past four year manag reshap compani
effici high-qual platform growth effici cost save book
past year qualiti averag star rate
period lhcg acquisit almost famili earlier year nearli doubl
size compani extend reach senior
pre-deal newli expand geographi open access new pipelin
potenti health system jv partner
risk horizon home health howev expect implement new
home health reimburs system industri still year
lobbi chang new system current design system repres
potenti challeng provid given behavior assumpt includ
model provid may find way mitig headwind time roll around
implement remain risk nonetheless current multipl think upsid
potenti balanc potenti risk medicar chang
encompass ew lead irf platform industri smaller fast
grow home health platform irf segment continu benefit
demograph tailwind averag patient year old strong track
record build denovo inpati rehab facil well visibl pipelin facil
come on-line next two year home health platform revenu
continu benefit manag collabor strategi drive referr volum
ehc irf market compani presenc
segment ehc home health agenc current captur irf
discharg overlap market number expect grow meaning higher
come year although new reimburs model schedul may present
temporari headwind segment ebitda growth
select medic ew irf platform produc strong growth compani
continu execut jv strategi lead health system pipelin visibl
cumul capac growth next year ultim howev fast
grow irf segment current revenu view major
busi segment low single-digit grower
manag larg mitig ltach criteria phase-in nearli rebuild
censu higher acuiti compliant patient back pre-criteria level still room
addit censu growth long-term see segment grow low single-digit
addit us healthwork earlier year concentra segment
own treat workplac injuri integr us
healthwork potenti least synergi period
compani bring margin in-lin legaci concentra busi long-term see
segment grow volum low single-digit rang
full disclosur cover compani includ detail company-specif valuat methodolog risk pleas refer
dialysi patient volum steadili grow per year high visibl rariti
healthcar provid univers lead caus end-stag renal diseas
diabet center diseas control cdc forecast grow preval
next decad current cure end-stag renal diseas
patient requir either life-sav dialysi treatment kidney transplant surviv
increas push value-bas care arrang dialysi could offer
signific avenu industri growth dialysi patient elig enrol medicar
advantag begin dialysi patient act nearli sponsor
us hous repres would creat esrd-specif model coordin care
develop could allow dialysi provid nephrologist manag
entireti patient healthcar coordin integr model would
repres materi revenu ebitda opportun industri
gener biosimilar altern key drug provid conjunct dialysi treatment
offer potenti reduc cost dialysi clinic estim erythropoiesis-stimul
agent esa repres approxim dialysi facil cost
potenti increas commerci mix msp extens legisl
propos congress extend medicar coordin period
month extens msp period would result increas commerci
treatment mix declin medicar mix sinc medicar reimburs significantli less
commerci insur dialysi improv commerci mix would drive
margin expans provid industri yet success get
provis pass although gain momentum congress
commerci revenu pressur provid seen declin
commerci revenu mix past year pressur come controversi
surround charit premium assist program began believ
major pressur behind industri commerci revenu mix continu
lag remain key risk
commerci rate significantli higher govern rate dialysi creat
signific cross-subsid signific major dialysi patient receiv coverag via
govern insur program histor paid rate insuffici cover
cost treatment commerci insur rate three four time higher govern
reimburs rate result entireti industri profit driven
dialysi patient popul cross-subsid persist part
commerci insur gener requir cover dialysi patient
period patient requir drop commerci plan go enrol medicar
primari coverag therefor limit exposur high-cost popul
charit premium assist come increas scrutini recent year
charit premium assist program american kidney fund ceas
would repres materi neg industri
advanc medic technolog could disrupt dialysi busi model
develop new drug slow revers progress chronic kidney diseas
could suppress industri volum growth avail wearabl artifici organ
replac could reduc demand dialysi treatment
signific major dialysi patient mix govern sponsor program
dialysi marketplac domin two larg nation dialysi organ
freseniu medic togeth two control market
follow hand smaller player market share includ publicli trade
approxim million adult unit state chronic kidney diseas
ckd ckd progress stage ckd end-stag renal
diseas requir either routin dialysi treatment transplant surviv
patient reli life-sav dialysi treatment provid primarili
freestand dialysi clinic addit live kidney transplant
past year dialysi patient popul grown averag annual rate
expect continu growth rate forese futur
larg degre due high preval diabet lead caus chronic
kidney diseas unit state
annual spend outpati dialysi treatment provid clinic across
lead indic dialysi volum
lead caus kidney diseas diabet hypertens drive
esrd case unit state respect diabet particular remain
epidem unit state nearli american diseas
million new case diagnos year center diseas control estim
one-third american today pre-diabet
lead caus end-stag renal diseas
center diseas control barclay research
center diseas control barclay research
recent studi publish journal popul manag forecast number
american diabet increas ten-year period end
rate growth excess five time growth overal popul
progress diseas chronic kidney diseas like advanc stage renal
failur requir dialysi popul age group twice
like develop esrd age group age group fastest
grow popul us nearli three time like progress esrd requir
dialysi next year popul expect grow fast
overal popul popul expect grow fast
overal popul
although dynam contribut industri volum growth current medicar
reimburs significantli less commerci reimburs result littl
contribut margin increment medicar patient howev expect shift
tradit fee-for-servic dialysi popul toward risk-bas arrang
next year present meaning opportun industri
new end-stag renal diseas case per million popul age group
popul expect growthu growth rate vs us esrd per million popul barclay servic
age popul us popul forecast
dialysi industri uniqu among provid sub-sector individu kidney
failur requir dialysi transplant qualifi medicar enrol regardless age
financi situat patient prefer maintain exist commerci insur
coverag despit medicar elig may also keep commerci plan
maximum month medicar automat becom patient primari
insur reason nearli dialysi treatment provid patient
govern insur primari coverag tradit medicar
fee-for-servic primari insur plan
histor medicar paid dialysi clinic revenu per treatment roughli equival
oper cost commerci cross-subsid lower govern reimburs
rate common among healthcar provid near univers receiv higher rate
commerci insur govern payor howev situat dialysi
particularli acut due high govern patient mix major typic
dialysi clinic margin gener dialysi patient maintain
popul acceler next decad babi boom gener age barclay servic
chart repres number provid fully-load basi
medicar patient may profit industri estim gener
posit contribut margin typic clinic
dialysi industri volum revenu profit mix
averag govern reimburs rate approxim per treatment
averag commerci rate roughli per treatment histor
reason driven materi diverg first law commerci insur plan
respons pay first month patient dialysi treatment
result cost save commerci plan longer need cover extrem
annual cost care esrd patient beyond first diagnosi second
medicar made avail esrd patient result mani patient drop
commerci plan develop esrd asid insur incent also
difficult hold job dialysi patient undergo treatment hour
per week univers govern coverag offer esrd patient result fewer
high-cost dialysi patient commerci insur book togeth two regulatori
featur shift signific cost insur industri book onto
govern dialysi industri also rel consolid result industri
leverag payor local market furthermor dialysi popul rel
small estim commerci dialysi patient entir us
highli vulner patient miss treatment often wind hospit incur
significantli higher cost signific incent insur ensur patient
receiv high-qual uninterrupt care
typic dialysi facil roughli squar feet consist dialysi station
employe includ medic director rn technic staff
major center leas found among retail storefront medic build
stand-alon clinic
develop new clinic requir approxim invest compos
leasehold improv capit expenditur work capit often take year
new clinic ramp capac point expect gener
revenu
dialysi treatment take hour complet patient requir treatment per
week clinic often run shift monday/wednesday/friday shift
tuesday/thursday/saturday result maximum patient capac
practic due turnov roughli given year clinic run full
capac averag close patient treatment per year
sinc end-stag renal diseas patient elig medicar coverag
regardless age financi situat esrd remain diseas elig
medicar coverag dialysi servic benefit provid
medicar program due elig approxim dialysi patient
cover medicar
laboratori servic medic
equip suppli esrd relat drug includ bundl includ part drug
primarili epogen iv iron iv vitamin part oral esrd-rel drug
inject equival primarili calcimimeti phosphat binder exclud
payment bundl oral drug inject equival avail
market includ bundl
base payment rate per treatment base rate adjust patient
characterist includ age bodi mass index comorbid adjust
patient first four month dialysi payment rate adjust facility-
specif characterist includ adjust clinic rural locat clinic
low-volum
base rate differ home in-cent dialysi howev provid receiv
train add-on payment per treatment session periton dialysi
session hemodialysi
payment updat annual esrd market basket adjust
product adjust protect access medicar act pama also
reduc updat
peopl esrd requir dialysi treatment gener qualifi medicar enrol
base diagnosi diseas esrd patient typic enrol medicar
physician prescrib dialysi treatment medicar secondari payer provis
social secur act requir patient enrol commerci group insur plan
insur plan remain primari payer period month time
call coordin period medicar secondari payer conclus
month coordin period medicar becom primari payer
result commerci insur dialysi patient lose commerci insur
coverag primari month start dialysi month wait period
medicar enrol msp period begin msp provis
result higher medicar lower commerci patient mix industri
serv exacerb rate differenti time
sinc govern reimburs rate significantli lower commerci rate
extens msp coordin period would result boost industri legisl
propos congress extend msp coordin period
industri yet success get provis pass
estim extens msp coordin period could
worth boost oper incom depend price assum
commerci rate would ultim declin modestli limit oper incom benefit
industri
januari new calcimimet drug parsabiv ad medicar bundl
payment rate parsabiv first inject calcimimet avail market class
drug use treat miner bone diseas common dialysi patient prior
introduct parsabiv oral calcimimet avail market sensipar
sinc oral drug exclud bundl payment system paid separ
medicar part introduct iv calcimimet requir add reimburs
class iv drug bundl rate
mechan ad new part drug bundl requir drug
reimburs separ two year base averag price drug
use claim data fulli incorpor cost drug bundl rate
therefor dialysi clinic receiv per dialysi treatment depend
mix drug provid provis calcimimet
iv version cincalcet parsabiv remain patent protect patent
oral version sensipar expir march fda approv gener
version drug expect avail
meantim expect increas bundl rate calcimimet earli
base medicar claim experi period given recent
util trend estim bundl payment rate could increas per
treatment inclus calcimimet would expect revenu neutral
industri howev bundl rate flat per treatment rate
vari base underli cost treatment introduct gener
dialysi set may offer opportun clinic reduc cost
futur opportun coordin esrd
one key overal theme across healthcar landscap past sever year
shift toward value-bas care value-bas care arrang expect
increasingli see provid organ incentiv reduc cost throughout
system averag esrd patient cost healthcar system roughli per year
esrd patient repres less popul account total
medicar spend patient complex healthcar need requir visit multipl
provid care plan make high-cost chronically-il popul exampl
opportun meaning reduc cost
histor abil manag care popul limit primarili due
govern reimburs structur nearli patient cover
govern insur primarili tradit medicar fee-for-servic patient
esrd also histor prohibit enrol medicar advantag plan
result fragment care dialysi clinic respons administ
dialysi treatment three day per week hour per day howev incentiv
manag care outsid dialysi treatment consist nearli half annual
healthcar cost esrd patient
sever initi attempt increas coordin care dialysi patient
esco form innov center comprehens esrd cec
model demonstr project aim assess impact care coordin
esrd patient dialysis-cent orient account care set dialysi clinic
nephrologist provid hospit join togeth creat joint ventur
coordin healthcar need patient model incentiv dialysi
provid support patient-cent coordin care aim provid better
outcom reduc cost insid outsid dialysi clinic
dialysi organ elig receiv share save payment also liabl
share loss base benchmark overal spend program began septemb
expect run decemb current esco
particip second year program includ freseniu
small dialysi provid year result program releas
octob particip drove save vs benchmark averag
save rang year result yet releas
esrd patient gener prohibit enrol medicar advantag plan
unless alreadi enrol plan prior develop esrd decemb
presid obama sign centuri cure act law allow esrd
patient enrol plan begin calendar year
expect dialysi provid increasingli enter risk-bas arrang medicar
advantag plan case offer esrd-focuss plan popul shift
toward coordin medicar advantag option approxim dialysi patient
current enrol plan number could move significantli higher
next year estim mani medicar ff esrd beneficiari could
incentiv enrol medicar advantag plan time given potenti out-of-pocket
save increas benefit offer increas coordin care
shown tabl approxim dialysi patient enrol
medicar fee-for-servic exclud ma-snp etc approxim half patient
dual elig medicar medicaid believ patient would
incentiv choos dual-snp plan due increas benefit care
coordin exampl assum beneficiari would choos
ff similar current overal penetr although number could
significantli higher among popul
approxim nearli ff patient current access medigap
today due state regul state current allow medigap insur plan deni
coverag esrd patient age medigap cover part dialysi
coinsur howev avail age state sinc
tradit medicar program limit pocket expens beneficiari without
access medigap out-of-pocket cost reach per year
assum materi beneficiari without medigap option
choos enrol medicar advantag plan due lower out-of-pocket
dialysi patient access
integrated-car empower nephrologist
treatment servic patient demonstr act first introduc septemb
act would establish
integr care program dialysi patient
interdisciplinari team led nephrologist provid comprehens manag
patient healthcar need
similar esco act would establish esrd-specif model coordin care
would enabl dialysi provid bear full risk care esrd popul
dialysi clinic act medic home addit improv access care coordin
bill would allow supplement benefit beyond tradit medicar offer
transport nutrit offer flexibl partnership option nephrologist
establish incent provid model entiti would also qualifi advanc
altern payment model apm make particip nephrologist elig
macra bonu payment exempt mip report requir
sinc dialysi patient alreadi visit dialysi clinic three time per week
program would use clinic central command point patient coordin
healthcar servic improv support common esrd comorbid
cardiovascular diseas diabet hypertens coordin model would aim
dialysi ff esrd elig medicar dual elig enrol benficiari medigap increment esrd /year indsutri revenu revenu opportun barclay servic
reduc overal cost care dialysi popul roughli half healthcar
cost incur typic dialysi patient outsid dialysi set today includ
high hospit rate patient act would enabl team-bas approach led
patient nephrologist primari goal maintain patient health
prevent hospit reduc cost
patient act current cosponsor hous cosponsor senat
charit premium assist dialysi
mani kidney failur patient unit state receiv assist non-profit
american kidney fund akf form health insur premium support via
health insur premium program hipp akf cover premium medicar part
plan cobra plan signific major akf annual budget fund
provid gener prohibit law offer form remuner
medicar medicaid beneficiari may like influenc individu choic
provid dialysi provid organ may directli pay premium behalf
patient howev bona fide chariti permit offer premium assist
beneficiari oig advisori opinion akf expressli permit
pay medicar part medigap premium behalf dialysi patient
issu opinion oig conclud contribut akf compani
made behalf beneficiari moreov premium payment
akf may constitut remuner behalf beneficiari like influenc
patient order receiv servic particular provid short oig conclud
akf provid suffici insul payment made akf
patient attribut compani therefor violat
industri oper arrang twenti year howev
passag afford act subsequ implement healthcar
insur exchang new avenu coverag open creation
exchang akf began pay premium dialysi patient wish enrol
individu commerci health plan via exchang result uptick
commerci mix dialysi provid period correspond
increas profit due higher rate paid commerci exchang plan
rel govern reimburs
earli akf premium subsidi payment individu marketplac exchang
plan becam scrutini particularli larg number exchang plan
run signific neg margin particip exchang result
controversi whether akf fund premium exchang coverag
respons variou statement industri effect suspend support
applic premium assist patient enrol plan also qualifi
current bill hous hr access marketplac insur act
introduc would make charit assist exchang plan premium
explicitli permiss law decemb bill cosponsor
ad last six month dont anticip movement near-
term bill eventu becom law could open door dialysi patient
use charit premium assist payment enrol exchang plan
would present signific posit industri
dialysi
individu end-stag renal diseas esrd requir either dialysi kidney transplant
surviv dialysi treatment use substitut declin function healthi
kidney patient esrd kidney function filter wast excess fluid
blood excret urin dialysi requir kidney lose
abil benchmark known stage chronic kidney diseas end-stag
renal diseas esrd cure end-stag renal diseas
chronic kidney diseas ckd progress diseas character gradual loss
kidney function accord center diseas control million peopl us
estim ckd lead caus chronic kidney diseas type
diabet high blood pressur glomerulonephr inflat kidney filter
unit take toll kidney function damag filter unit factor
contribut risk chronic kidney diseas includ smoke obes age
averag age patient start dialysi year old
progress kidney diseas slow earli intervent howev mani
peopl show symptom later stage ckd kidney diseas often refer
silent diseas less stage ckd even awar
approxim one-third patient progress esrd receiv littl pre-esrd
care nephrologist
two type dialysi treatment hemodialysi periton dialysi
hemodialysi common dialysi treatment us util filter call
dialyz remov wast maintain balanc chemic within blood
patient connect hemodialysi machin via surgic creat access point
typic locat arm blood pump machin
dialyz compris two section separ thin membran blood pass
one section fluid call dialys side blood pass
membran larger particl blood cell remain smaller molecul
urea creatinin potassium excess fluid pass membran wash
away dialys
hemodialysi commonli perform free-stand dialysi clinic treatment
usual done time per week hour per treatment
periton dialysi pd similar hemodialysi except periton dialysi util
line abdomen peritoneum clean blood abdomen fill
dialys fluid surgic implant cathet left absorb wast
periton line fluid exchang either manual continu ambulatori periton
dialysi capd assist machin continu cycler-assist periton
dialysi ccpd periton dialysi typic perform home ccpd usual
done night patient sleep
periton dialysi offer advantag hemodialysi hemodialysi remain
domin form dialysi less patient pd factor influenc
includ lack train awar financi disincent patient abil
willing administ treatment home
end-stag rental diseas patient receiv kidney transplant either live donor
one kidney requir bodi cadav transplant typic offer
freedom better qualiti life dialysi fewer limit patient
eat drink transplant recipi need spend mani hour per week
dialysi clinic transplant recipi often get back kind life
live kidney diseas transplant typic last rest recipi
life howev mani peopl need one transplant lifetim go
dialysi transplant kidney longer function
transplant complet often desir option esrd
patient number organ avail year limit peopl wait
organ transplant unit state wait kidney vs
annual kidney avail roughli kidney receiv deceas
donor remain live donor
due limit organ avail newli diagnos esrd patient
receiv transplant lieu begin dialysi
annual kidney transplant newli diagnos esrd patient
american renal associ hold inc quarterli annual ep usd
consensu number thomson reuter receiv gmt
initi coverag american renal associ equal weight rate
price target
denovo physician jv strategi differenti exclus focuss partner
physician within local market build dialysi facil via ara-physician
joint ventur compani differenti strategi provid partner nephrologist
autonomi run clinic feel appropri ara oper structur provid
physician altern larg dialysi organ domin dialysi
market creat competit advantag recruit new partner denovo clinic
law larg number result slow top-lin growth expect
compani continu add clinic per year next sever year help
drive annual treatment growth vs treatment growth overal
industri sign deal denovo clinic pipelin
new contract unitedhealthcar provid stabil follow multi-year contract
impass unitedhealthcar sign new agreement insur
effect august new in-network contract remain ebitda
headwind per month drag juli offer opportun
grow commerci volum unit next sever year
highli visibl volum growth dialysi industri patient volum steadili grow
per year high visibl rariti healthcar provid univers lead caus
end-stag renal diseas diabet forecast grow preval
next decad current cure end-stag renal diseas patient requir
either life-sav dialysi treatment kidney transplant surviv
medicar rate outlook posit dialysi provid incur legisl rate
reduct recent year account declin drug spend specif epo
reduc market basket updat last
reduct took place rate slate increas
compar averag updat seen past three year repres
strongest medicar rate updat industri sinc
patient medicar rate updat repres meaning relief provid extra
medicar rate provid tailwind
price target assum stock trade ev/ebitda-nci
estim repres premium dialysi peer given stronger
american renal associ headquart beverli massachusett dialysi servic
provid unit state focus joint ventur partnership physician
compani current oper dialysi clinic partnership
nephrologist treat patient state district columbia
jv-focuss model american renal associ own averag interest
clinic nephrologist partner hold interest believ jv model
gain preval dialysi servic model nephrologist grow
rapidli past sever year accord american societi nephrolog
approxim nephrologist unit state believ signific
portion physician treat patient clinic ownership
interest septemb partner nephrologist
believ jv model provid signific benefit patient provid payor
core valu jv model superior align interest achiev
physician partner model design free physician administr
task focu patient outcom provid physician practic manag
back-offic oper believ nephrologist view dialysi clinic
extens practic oper infrastructur help nephrologist
deliv better care addit compani pride allow physician
partner clinic flexibl provid care see fit includ choic drug
protocol believ give competit advantag look new
includ cost hospit physician visit non-dialysi prescript drug
non-dialysi servic averag medicar dialysi patient cost system roughli
per year third amount per year spent
care provid outsid dialysi includ averag day spent hospit per
due silo natur medicar fee-for-servic reimburs primari
payor dialysi patient care dialysi patient receiv
coordin signific way dialysi clinic care nephrologist see
esrd patient three time per week hour per day repres signific
opportun influenc patient behavior adher medic nutrit
protocol medicar reimburs dialysi clinic bare cover variabl cost
take care patient howev make near imposs clinic invest
program could significantli reduc overal cost care
industri lobbi materi shift toward coordin care dialysi
popul see dialysi industri section detail discuss
opportun increas coordin risk-shar includ medicar advantag
dialysi patient act
effect august enter new in-network three-year contract
unitedhealthcar across ara clinic state dc includ uhc
commerci medicar advantag medicaid busi agreement also includ
value-bas contract featur goal reduc hospit cost uhc
plan particip receiv care clinic
new in-network contract price result per month drag y/i ebitda
growth anniversari august return in-network uhc
howev enabl begin rebuild volum payor compani
in-network contract uhc sever year
recent slowdown denovo period
latest earn call manag discuss slow-down compani seen
time get new clinic construct approv profit reason cite
longer typic ramp-up period denovo clinic includ tighter construct
market longer lead time get clinic run experienc histor
backlog get approv new clinic someth dealt
industri larg expect backlog larg mitig start
accept third parti certif new clinic expect contribut
growth denovo open somewhat lower next year primarili
due critic mass compani gain law larg number anticip
compani new treatment growth guidanc fall rang go forward
modestli initi guidanc rang issu last year
potenti increas commerci mix msp extens
legisl propos congress extend medicar coordin period
month extens msp period would result increas
commerci treatment mix sinc medicar reimburs significantli less commerci
insur dialysi improv commerci mix would drive margin expans
provid industri yet success get provis pass
although gain momentum congress
estim extens would drive boost commerci revenu
repres consolid revenu pickup prior consider chang
price dynam increment revenu would fall straight bottom line given
would pure chang mix increment cost although would expect
price deterior given increment cost face insur
recommen clinic physician place practic medicinei proud tell peopl affili clinici confid leadershipthi clinic treat physician respectif practic medicin three year confidenct work clinicthi clinic provid high qualiti care servicei adequ input clinic decis affect practic medicinen dialysi facilityr clinic staffrat nephologistsindustri average barclay servic
open lh y/i contribut growth treatmentsnon-acquir tx treatmentsy/i contribut growth akf hix charitableassist declineiv calcimimet begin barclay servic
incom stock ebitda-nci barclay servic
 expens compens expens sale debt issuance/term lt exercis stock sale barclay servic
davita inc quarterli annual ep usd
consensu number thomson reuter receiv gmt
initi coverag overweight rate price target
opportun expand dialysi risk-tak revenu expans next
year increas push value-bas care arrang dialysi
could offer signific avenu industri growth dialysi patient elig enrol
medicar advantag begin dialysi patient act nearli
sponsor us hous repres would creat esrd-specif model
coordin care develop would allow dialysi provid manag
entireti patient healthcar coordin integr model
repres materi revenu ebitda opportun industri
materi accret sale dmg adequ reflect process
sell under-perform davita medic group subsidiari
cash proce expect pay debt go toward materi share purchas
current level estim compani could repurchas nearli share outstand
proce debt paydown maintain net leverag pro-forma
transact see compani net debt less current trade rang
impli pro-forma ebitda-nci multipl ebitda near two-turn discount
histor rang averag ev/ebitda turn
discount unadjust rang prior announc dmg sale
commerci mix still risk alway view risk/reward favor current
level share trade week follow earn part due
concern commerci mix model assum commerci mix headwind
scenario view like prove conserv six largest
nation health plan payor lock multi-year contract manag
character unusu posit level long-term stabil commerci
risk remain ever-pres dialysi invest thesi believ share
over-discount likelihood materi mix headwind
medicar rate outlook posit dialysi provid incur legisl rate reduct
recent year account declin drug spend specif epo reduc market
basket updat last
reduct took place rate slate increas compar
averag updat seen past three year repres strongest
medicar rate updat industri sinc patient
medicar rate updat repres meaning relief provid extra
medicar rate provid tailwind
highli visibl volum growth dialysi patient volum steadili grow per year
high visibl rariti healthcar provid univers lead caus end-
stage renal diseas diabet forecast grow preval next
decad current cure end-stag renal diseas patient requir either
life-sav dialysi treatment kidney transplant surviv
price target assum stock trade ev/ebitda-
nci estim ev/ebitda pro-forma sale dmg
repres turn discount histor trade rang given recent concern
commerci mix
davita core us dialysi relat lab servic busi compris approxim
consolid revenu busi lead provid outpati dialysi servic
unit state serv approxim patient network
outpati dialysi clinic state district columbia also provid
acut inpati dialysi servic hospit contract per-treat basi
account approxim revenu compani also own two clinic
laboratori special esrd-rel laboratori test provid routin lab test
network esrd patient
addit us dialysi busi compani also provid numer dialysi
relat servic ancillari strateg initi busi revenu
segment primarili consist compani pharmaci busi diseas
manag servic vascular access servic
pharmaci special oral medic medic manag
servic patient esrd pharmaci busi current gener roughli
break-even profit margin object pharmaci reduc overal care
cost facilit increas complianc mani prescript medic davita
patient requir manag busi expect contribut
significantli oper incom import maintain qualiti outcom
like becom strateg import dialysi clinic increasingli look
manag coordin healthcar need esrd patient
villagehealth subsidiari provid popul health manag
servic late-stag chronic kidney diseas esrd patient compani manag
care patient partnership health plan well
chronic condit special need plan c-snp esrd seamless organ
esco contract typic includ share save payment relat target cost
save case fulli capit
also oper dialysi clinic ten countri locat outsid us
gener revenu annual consolid revenu compani
earli stage grow intern dialysi oper revenu nearli
doubl past two year although intern divis current run near
break-even oper incom compani continu invest busi growth
includ cost hospit physician visit non-dialysi prescript drug
non-dialysi servic averag medicar dialysi patient cost system
roughli per year third amount per year
spent care provid outsid dialysi includ averag day spent
due silo natur medicar fee-for-servic reimburs primari
payor dialysi patient care dialysi patient receiv
coordin signific way dialysi clinic care nephrologist see
esrd patient three time per week hour per day repres signific
opportun influenc patient behavior adher medic nutrit protocol
medicar reimburs dialysi clinic bare cover variabl cost take care
patient howev make near imposs clinic invest program could
significantli reduc overal cost care
industri lobbi materi shift toward coordin care dialysi
popul see dialysi industri section detail discuss
opportun increas coordin risk-shar includ medicar advantag
dialysi patient act
estim everi medicar ff patient shift capit coordin
care arrang could worth oper incom oper margin
earn sensit coordin penetr margin
oper incom increas given ff shift coordin care margin
us patient mdcr ff shift coordin coordin esrd patient pmpi average spend inflat dialysi portion alreadi capit dollar per patient per manag revenu per year savings/margin margin op incom op incom shift coordin savings/ margin barclay servic
earlier year reach agreement unit healthcar sell
medic group unitedhealth group optum subsidiari cash
purchas busi formerli known health partners/hcp
sinc acquisit asset under-perform part due chang medicar
advantag rate past sever year remain signific overhang
compani oper incom declin
sale announc decemb current await regulatori
approv ftc latest develop california dept manag
healthcar approv deal two week ago estim tax basi dmg asset
like near sale price expect minim tax leakag sale
manag indic intend pay debt maintain leverag within
compani histor rang debt/ebitda estim assum
net cash proce sale allow leakage/oth invest
spend compani could repurchas worth stock current level exit
net leverag ratio debt/ebitda
would impli share repurchas approxim outstand share
pro-forma transact see compani net debt less
ebitda-nci multipl ebitda full turn discount past
impli pro-forma ebitda-nci multipl ebitda near two-turn
discount histor rang turn discount unadjust rang prior
announc dmg sale
net net repo net leverag share o/ share net price barclay servic
discuss dialysi industri section major near dialysi
fee-for-servic medicar rate howev significantli lower commerci rate
averag result commerci book busi drive margin busi
past year commerci mix come pressur primarili due
declin healthcar exchang membership among dialysi popul result
chang akf charit premium assist program see industri section
detail discuss program incur estim
oper incom reduct reduct healthcar exchang coverag
due elimin akf subsidi certain patient popul exchang
compani estim individu still receiv premium assist
exchang lose premium assist would repres
recent compani cite slight shift mix within commerci book
toward plan whose rate lower ytd mix deterior approxim
model assum approxim commerci mix headwind
contempl commerci patient incur price cut averag via
either lower rate shift plan pay lower rate scenario view like
prove conserv current contract five largest six nation health
plan payor lock multi-year deal situat manag character
unusu posit level long-term stabil
potenti increas commerci mix msp extens
legisl propos congress extend medicar coordin period
month extens msp period would result increas
commerci treatment mix sinc medicar reimburs significantli less commerci
insur dialysi improv commerci mix would drive margin expans
provid industri yet success get provis pass
although gain momentum congress
estim extens would drive boost commerci revenu
repres consolid revenu pickup prior consider chang
price dynam increment revenu would fall straight bottom line given
would pure chang mix increment cost although would expect
price deterior given cost insur assum declin price
estim extens could drive greater increas oper incom
dialysi revenu price price oper incom dialysi treatmentsnon-acquir growth barclay servic
incom y/i q/q na na na na na na na patient bad incom y/i y/i expens incom y/i share barclay servic
balanc term current tax current total payabl compens payabl portion long-term expens current current long-term incom tax total interest redeem liabil barclay servic
incom valuat loss incom debt compens invest loss non-cash current long-term compens current long-term net provid oper properti busi purchas advanc interest net provid use invest long-term financ tax benefit stock interest minor non-controlling sale add non-controlling proce issuanc common treasuri net provid use financ increas decreas barclay servic
median p/emediandva rel spx barclay servic
post-acut industri care patient typic recov acut
episod ill injuri nearli half acut care hospit stay follow
form post-acut care skilled-nurs facil receiv largest portion patient
see million case per year roughli one five medicar patient
discharg acut care hospit follow health inpati rehab
facil irf long-term acut hospit ltach
estim overal market post-acut care approach per year led
skill nurs facil snf estim revenu exclud non-skil
institut care home health revenu irf revenu
ltach revenu
post-acut industri site
post-acut psych acut inpati ltchirfsnf-u size case length daysmedicar barclay servic
post-acut crossroad opportun threat
healthcar system unit state continu shift toward value-bas care
expect focu post-acut care intensifi whether via medicar incentiv payment
reform bundl payment program increas penetr medicar advantag
fee-for-servic pressur risk-bas contract commerci insur plan
post-acut industri like face signific chang come decad
time rapid growth popul popul
particular like drive increas demand servic us popul
expect grow nearli next decad compound-annual-growth-rate vs
compound-annual-growth-rate babi boom gener age popul util
significantli care even year-old popul health util
rate three time higher year-old popul hospic
util nearli seven time higher inpati hospit util rate nearli twice
high rel year-old popul
util rate per popul
popul acceler next decad babi boom gener age acut hospicenurs rel barclay servic
us popul growth forecast million
hospit util rate per
us censu dept human servic barclay research estim
increas demand servic shift payment model coupl
consolid local hospit market mean post-acut provid need
continu evolv way compet busi
hospit remain primari referr sourc post-acut provid due
increas preval quality-bas reimburs payment reduct
readmiss value-bas contract bundl payment mani hospit system
look limit referr select number post-acut partner within market
environ post-acut provid offer wide array post-acut servic
across hospit system geograph coverag area demonstr qualiti outcom
like see increas market share similarli refer hospit increasingli
respons cost care patient discharg hospit post-acut
provid need demonstr valu requir cost effici
abil commun valu servic extern partner expect post-acut
provid continu invest data analyt clinic effect compar
valu improv upon oper effect demonstr
valu provid referr sourc system larg
site acut gener acut hospit
long-term care hospit ltach provid extend acut care treatment clinic
complex condit chronic critic ill requir hospital-level care
extend period patient averag length stay excess day significantli
longer averag length stay gener acut care hospit
common categori condit treat ltach respiratori diseas typic patient
ventil repres ltach admiss follow wound
care nervou system disord complic infect cardiac complic ltach
freestand facil fs colloc gener acut hospit refer
hospit within hospit satellit medicare-certifi ltach
unit state includ freestand facil unit within acut care
hospit ltach oper for-profit entiti
acute| -- -- -- -- -- -- -- -- -- -- -- -post-acut -- -- -- -- -- -- -- -- -- -- -- -|short-term acut inpati ltchirfsnfhome-u size case length daysmedicar barclay servic
medicar predomin sourc ltach revenu compris two-third ltach
discharg annual spend past five year revenu oper
margin declin primarili driven chang medicar reimburs criteria
ltach see expect industri volum revenu margin stabil
ltach expect fulli transit new payment regim patient
criteria begin
compani ltch specialti management barclay servic
ltach face signific chang past year due regulatori chang
signific among chang implement new medicar
sign law decemb balanc budget act establish new
requir reimburs care insid ltach effect period begin
octob new criteria effect creat two-tier reimburs system
order qualifi ltach reimburs patient must discharg
acut care hospit either spent least day intens care unit icu
acut care hospit must receiv least hour ventil servic
ltach stay addit criteria specif exclud patient whose principl
diagnosi psychiatr rehabilit natur
patient meet criteria medicar reimburs ltach lower
site-neutr rate defin lower equival acut care hospit ipp rate
underli cost provid servic legisl establish transit period
ltach paid blend higher ltach rate lower
site-neutr rate transit period end period begin octob
discharg meet criteria paid site-neutr rate
addit effect octob order maintain medicar statu ltach
facil must least discharg fiscal year patient
meet criteria less facil discharg meet patient criteria
facil paid lower site-neutr rate follow year
site-neutr rate estim averag ltach rate
moratorium new ltach
variou law year impos moratorium open new ltach
increas ltach bed exist facil moratorium
develop expans ltach place decemb
although number facil still expand period recent
pathway sgr reform act enact decemb place
moratorium establish new ltach increas number
bed exist ltach facil new facil bed expans approv
prior april gener exempt moratorium effect april
septemb
rule limit referr sourc
final commonli refer rule requir
ltach hwh/satellit locat within yard hospit campu less
admiss come colloc acut care facil volum exce
threshold paid lower acut care ipp rate rule intend
prevent acut care hospit use colloc ltach extens hospit
sever subsequ rule legisl action roll back delay
implement rule final ltach rule publish earlier year
elimin rule entir
acut site
physic occup speech therapi patient typic follow ill injuri
surgeri patient averag length stay day disproportion
year older order qualifi irf stay medicar beneficiari must abl
toler benefit least three hour therapi per day contrast snf
acute| -- -- -- -- -- -- -- -- -- -- -- -post-acut -- -- -- -- -- -- -- -- -- -- -- -|short-term acut inpati ltchirfsnfhome-u size case length daysmedicar barclay servic
beneficiari typic requir one hour therapi day per week irf
freestand facil unit within acut care hospit
qualifi medicar reimburs irf facil must meet certain criteria
notabl rule aim ensur irf primarili engag provid
intens rehab servic rule requir least facil patient
popul includ non-medicar volum least one thirteen condit
typic requir intens therapi irf meet threshold
medicar pay case lower hospit inpati rate thirteen
condit specifi
three arthriti condit outpati therapi fail
hip knee replac bilater side time
patient patient older
commonli treat condit irf stroke neurolog patient
togeth compris one-third medicar patient treat irf
case compris larger share irf admiss past sever year
began enforc complianc threshold enact revis
distribut irf case vs
neurolog lower injuri joint replac lower cord barclay servic
began consist enforc irf complianc threshold revis
criteria limit number major joint replac case qualifi treatment
irf result declin number case oper margin
medicar predomin sourc irf revenu account
industri volum annual spend industri seen stabil
return growth follow enforc complianc threshold
period volum grown annual rate sinc total spend
increas period
begin enforc complianc threshold barclay servic
margin larg stabil follow disrupt caus cmss complianc threshold
chang freestand facil account irf enjoy significantli
higher margin hospital-bas irf unit differenti larg part driven
differ cost effici base encompass health oper
half freestand irf analysi data averag cost per discharg
encompass irf one-third averag cost rest industri serv
patient similar case mix intens lower revenu per discharg hospital-bas
unit receiv slightli higher averag reimburs per discharg oper
cost nearli higher encompass
encompass health compris nearli half freestand irf oper irf
averag significantli larger hospital-bas unit beds/facil vs per
hospit unit provid scale benefit drive significantli volum bed
discharg per bed per year vs hospital-bas unit benefit scale
effici best practic oper larg network irf
encompass health analysi data
encompass health analysi data
medicar primari payer irf discharg largest oper freestand
irf deriv revenu medicar fee-for-servic program
payment irf base adjust base payment rate discharg base
payment rate amount adjust differ area wage
rate patient case mix group patient characterist patient assign case-mix
group cmg base primari reason care stroke brain injuri hip fractur age
level motor cognit function within cmg patient
categor one four tier depend specif comorbid patient
rural facil rate increas tend fewer case longer
length stay higher averag cost per case case certain high-cost outlier
threshold set also receiv addit payment equal cost
threshold high-cost outlier base fixed-loss amount
outlier payment kick
irf base payment rate updat everi year irf-specif market basket
sinc passag afford act reduc year
measur multi-factor product factor addit annual statutori reduct
reduct annual market basket measur product expect
continu indefinit howev statutori reduct reduc net updat
past three year laps effect
acut site
health agenc provid servic beneficiari homebound need
skill nurs care physic therapi occup therapi speech therapi qualifi
medicar home health benefit beneficiari must unabl leav home
without consider effort need eight hour per day skill care
treat ill injuri half home health visit skill nurs
servic visit provis therapi servic
medicar certifi home health agenc us
highli fragment market
number health agenc
industri sustain signific reimburs rate cut result
afford act howev agenc manag larg mitig cut
shift type patient treat reduc visit per episod care
acute| -- -- -- -- -- -- -- -- -- -- -- -post-acut -- -- -- -- -- -- -- -- -- -- -- -|short-term acut inpati ltchirfsnfhome-u size case length daysmedicar agenc barclay servic
health patient number servic visit
hospic provis holist care patient end life famili
goal hospic care maxim qualiti life comfort cure hospic provid
medic care pain manag emot spiritu support tailor
individu patient need major hospic care provid patient home
although care also provid insid hospit nurs home long-
hospic care team typic consist patient physician hospic physician
nurs hospic aid social worker bereav counselor spiritu counselor
speech physic therapist need addit care patient hospic
team also provid support counsel patient famili
qualifi hospic care medicar benefit patient must gener agre
forego cur care signific major hospic care reimburs
estim hospic market grow next sever year
growth driven larg part popul growth year-old age group
growth rate popul particularli meaning hospic segment
averag util nearli averag year-old
util rate
market home health hospic care remain highli fragment top
player control market segment larger player
segment continu consolid industri
 hospic spendingy/i acut hospicenurs rel popul acceler next decad babi boom gener age barclay servic
medicar largest sourc home health revenu compris industri
medicar beneficiari qualifi home health care homebound mean
patient abl leav home without consider effort requir intermitt
skill nurs physic speech therapi receiv treatment plan care
establish period review physician approxim home health
episod refer physician follow hospit refer
directli commun
medicar rate base level sever patient condit provid
paid bundl rate base episod care episod
recertif assess done determin home care still need physician
determin care need anoth episod begin immedi
follow first
base medicar payment rate per episod adjust base
one home health resourc group hhrg reflect expect cost
particular episod patient group hhrg base clinic score base
rang clinic indic infus therapi wound statu etc function score base
patient abil perform basic task dress bath servic
util score base number therapi visit episod care
episod care unusu costli home health agenc may elig
outlier payment elig estim episod cost must higher
payment rate certain threshold set annual equal base
payment rate medicar reimburs differ estim cost
base payment rate updat annual latest rate increas
rankhom providermarket nurs servic total providermarket hospic live total barclay servic
reimburs chang pdgm
earlier year part rate set process propos overhaul
medicar home health reimburs system slate implement effect
import chang implement new case mix group
system move away episod care favor episod care
remov number therapi visit driver reimburs rate
new case mix system call patient-driven group model pdgm reli
heavili patient characterist new group base clinic diagnosi
complex nurs function statu low medium high admiss sourc
institut commun referr comorbid whether first second
episod patient model includ group expect base rate
congress mandat via bipartisan budget act move
episod care episod care budget neutral
controversi part rule assumpt make around behavior
chang reduc base rate account chang code
behavior assum number visit episod would increas slightli
move low-util threshold adjust expect increas
comorbid expect increas diagnost code intens
industri begun intens lobbi behavior reduct sinc
final chang full year ahead typic rulemak process still
remain signific amount time prior implement increas
probabl mitig prior implement
effect implement value-bas purchas hhvbp
model nine state program aim test whether incent better care
improv outcom home health program appli penalti offer bonu
payment agenc within program base perform
implement program home health agenc nine state effect januari
expect run end
hha benchmark base qualiti care deliv patient receiv
home health servic rel perform peer within state
well past perform qualiti measur calcul subset
measur current captur via outcom assess inform set oasi
health consum assess healthcar provid system hhcahp
patient servic hha
satisfact measur three new measur
base total score rel benchmark payment adjust given year
appli medicar payment two year perform year repres
first year payment base perform maximum penalti reward
payment first year increas final year
rewards/penalti value-bas purchas program
medicar cover hospic care beneficiari life expect six month
less determin physician rate paid per day regardless amount
servic provid given day rate set accord fee schedul four
differ level care routin home care rhc continu home care chc inpati
respit care irc gener inpati care gic major hospic day routin
level descriptionbas payment raterhchom provid day provid day provid period patient care short period provid respit primari care treat symptom manag anoth barclay servic
impact improv medicar post-acut transform act
impact act sign law octob
law mandat collect report standard patient data home
health inpati rehab irf long-term care ltach skill nurs facil snf
data collect begin includ function statu data mobil self care
admiss discharg cognit function data abil express idea understand
mental statu depress dementia special servic need
ventil dialysi chemotherapi central line medic condit comorbid
impair abil hear see swallow
act requir develop integr qualiti measur across post-acut
set includ hospit readmiss fall averag total medicar cost per
beneficiari hospit post-acut provid requir provid qualiti score
consum transit post-acut provid provid fail effect
collect report qualiti data subject penalti
medpac hh requir conduct studi report includ recommend
new post-acut care payment system pay provid base patient
characterist cognit abil function statu impair rather post-acut
site care hh irf ltach snf
site-neutr payment system post-acut could potenti game changer
industri term shift incent toward lower cost site care
believ like time-frame payment system least sever year
away hh medpac report includ recommend new payment system
due year although report often significantli delay actual
develop implement new post-acut payment system could take
number year recommend made
encompass health corp quarterli annual ep usd
consensu number thomson reuter receiv gmt
initi coverag encompass health equal weight rate
inpati expans drive near-term growth inpati rehabilit segment
compris consolid revenu ebitda-nci corpor
overhead encompass continu drive irf segment growth strong pipelin
denovo opportun well expans exist facil estim denovo facil
 expans bed contribut annual volum growth next
year expect compani continu benefit bed expans
denovo growth increas capac meet rise demand age
popul averag irf patient year old popul cohort
expect see growth acceler averag annual rate next
decad vs averag growth experienc sinc
inpati rehab home health collabor continu pay dividend expect
home health inpati segment becom increasingli coordin drive
increment home health volum revenu market
presenc segment overlap market home health agenc current captur
approxim home health discharg compani irf less
three year ago compani approach near-term target captur
irf discharg home health overlap market expect
meaning upsid target come year manag drive increas
collabor two segment continu gain scale home health
acquisit growth also contribut meaning home health segment growth
medicar reimburs medicar account inpati segment revenu
home health hospic revenu anticip improv annual rate updat
inpati busi mandat cut laps inpati home
health segment howev face signific chang reimburs system begin
anticip effect navig chang particularli given
longer averag lead time prior implement howev chang
introduc possibl near-term disrupt
price target base forward ev/ebitda-nci multipl
repres premium histor trade rang given growth opportun
lead owner oper inpati rehab hospit irf
leader home-bas care includ hospic servic compani offer servic
state puerto rico
compani inpati rehabilit segment oper irf
own via joint ventur variou hospit system compani oper
licens irf bed unit state provid medicar irf servic
compani health hospic segment oper home health hospic
locat across state make largest provid medicar skill home care
servic countri
compani segment heavili depend medicar reimburs
 irf health revenu deriv medicar ff patient
detail provid special rehab care approxim patient serv
compani irf admit acut care hospit follow physician referr
specif acut inpati rehab care patient gener suffer signific
cognit physic disabl due condit stroke hip fractur variou
neurolog condit condit non-discretionari natur gener
requir rehab care inpati set
unit state compani oper agenc
home health hospic busi fourth largest provid skill home health
state
concentr southeast region texa segment provid servic includ
skill nurs physic occup speech therapi medic social work home
health aid servic patient gener refer directli acut care hospit
inpati rehab facil directli physician without preced inpati stay
segment employe team regist nurs rn licens practic nurs lpn
therapist social worker home health aid segment also provid hospic servic
termin ill patient includ pain manag physic emot support
compani larg enter home health busi acquisit
ehhi hold decemb
strateg relationship lead strong irf growth
encompass long histori partner major healthcar system around
unit state irf own partnership local health system
gener signific referr sourc given market irf
admiss refer directli acut care hospit
compani strong track record develop new facil ad bed
sinc bed growth half ad via jv partnership
hospit system expect open denovo facil compris bed next
includ bed acquir part reliant transact
denovo expect open
addit new facil develop compani routin expand capac meet
grow demand within exist market past five year new bed
ad exist facil bed growth manag expect add bed per
year exist facil next sever year repres growth per year
new inpati bed ad exist facil
ad exist irf barclay servic
collabor part strategi
central part manag strategi revolv around clinic collabor
compani inpati home health segment manag refer market
compani oper inpati rehab hospit home health agenc overlap
market transit coordin place overlap market collabor
clinician case manag coordin transit inpati set
home manag expect care coordin help reduc number
discharg skill nurs facil increas number discharg home
beyond drive volum home health goal collabor strategi improv
outcom reduc total cost care across post-acut episod reduc snf
util favor home health result lower post-acut cost across system
import environ increasingli shift toward risk share
value-bas purchas manag launch work initi
indentifi extrapol best practic care coordin across overlap market
current approxim encompasss irf market character overlap
market compani home health locat within radiu irf
manag target collabor rate irf discharg captur
home health agenc within overlap market compani
achiev collabor rate manag believ drive
collabor rate closer next sever year estim everi
increas collabor rate would drive home health volum growth
data analyt innov
encompass form post-acut innov center collabor cerner corpor
develop analyt tool manag patient popul across post-acut
continuum care object innov center develop decis support tool
initi enhanc care coordin clinic outcom post-acut care network
perform reduc cost care across post-acut continuum
initi develop test includ post-acut readmiss
predict model model look use statist analysi identifi patient risk
readmiss across post-acut set util increas monitor intervent
aim reduc risk readmiss hospit
believ analyt develop key differenti compani
healthcar payment model continu evolv toward value-bas arrang
medicar reimburs rais near-term risk
addit net market basket updat final irf rule issu
juli continu propos chang case-mix classif system use assign
patient case-mix group payment histor use data captur via
function independ measur instrument fim score system assign patient
case-mix group length stay valu howev effect start
propos move away fim instrument data favor new patient
function data captur qualiti indic section irf patient assess
instrument irf pai chang intend budget neutral mani
industri concern qualiti irf pai data adequ could result
disrupt implement
locat disproportion weight toward southeast texa
compani file barclay research
compani file barclay research
irf hospic barclay servic
incom oper administr incom nonconsolid stock compens ebitda-nci excl stock y/i expens tax effect tax share barclay servic
balanc receiv net bad current current equip asset incom tax long-term liabil current portion long-term expens current current debt net current long-term perpetu prefer sharehold liabil barclay servic
operationsnet discontinu oper net reconcil net incom net cash provid oper activ depreci compens tax net incom nonconsolid nonconsolid doubt net asset liabil net acquisit account receiv asset payabl interest liabil paid redempt bond cash use oper activ discontinu oper cash provid oper properti equip capit softwar cost busi net cash acquir sale market chang restrict cash use invest common stock includ fee paid common exercis stock paid non-controlling interest consolid net cash use financ cash cash cash equival begin period cash equival end barclay servic
select medic hold corpor quarterli annual ep usd
consensu number thomson reuter receiv gmt
initi coverag equal weight rate price target one
largest provid post-acut care includ largest ltach platform
ltach state second largest irf platform irf state largest
outpati rehab clinic platform rehab clinic concentra subsidiari
also own largest occup medicin platform locat across state
inpati rehab bed expans drive near-term growth
consolid revenu sem inpati rehab segment experienc signific growth
continu expand compani execut upon jv partnership strategi
anticip compani add bed next year drive bed growth
build new irf lead health system partner digniti
us healthwork integr continu drive synergi sem concentra subsidiari
acquir us healthwork februari year combin compani treat
workplac injuri expect compani continu drive synergi
bring us healthwork margin line rest concentra opportun
vs margin time acquisit follow success integr margin
expans concentra acquisit us healthwork asset repres
ebitda opportun time period
manag larg mitig ltach criteria manag success rebuilt
censu follow phase-in new ltach reimburs criteria year-to-d
occup high case-mix revenu per day increas move
toward serv compliant patient expect manag drive censu modestli
higher still ultim see critic ill recoveri hospit segment ltach
grow low-singl digit next sever year
price target base forward ev/ebitda-nci multipl
ev/ebitda line histor trade multipl
discount peer post-acut provid given somewhat slower expect growth
found select medic one largest provid post-acut care us
compani largest oper critic ill recoveri hospit ltach
hospit state second largest oper inpati rehabilit hospit
irf state select also largest oper outpati rehab clinic
occup medic center rehabilit clinic across state
occup health center state concentra subsidiari
long-term acut revenu
compani long-term acut care hospit ltach make largest oper
facil us market share
major sem ltach oper hospit within hospit hih gener
hih leas space campu gener acut care hospit oper
separ licens hospit within host hospit
patient typic admit long-term acut care hospit follow intens care
unit stay gener acut care hospit patient tend highli special
complex need suffer chronic condit complic relat heart failur
infecti diseas respiratori failur pulmonari diseas complex surgeri requir
signific recoveri renal diseas neurolog event trauma due complex need
patient averag length stay compani ltach significantli longer
gener acut care stay day vs day averag acut care stay
focuss serv patient debilit injuri rehab need
adequ met less medic intens environ skill nurs facil
servic focuss individu patient need often includ ventil wean
wound care infect control custom mobil speech swallow program
describ industri section ltach criteria establish decemb
part legisl pass sustain growth rate doc fix effect
patient treat ltach receiv ltach specif payment rate
short-term acut care hospit icu stay prior admiss spend
least hour ventil ltach stay patient meet criteria
receiv lower site neutral rate
result select shift patient mix captur higher percentag ltach
compliant patient substanti admiss ltach criteria compliant
patient sinc implement criteria due shift mix patient treat
drgdischargesshar edema respiratori w/ vent support w/ ulcer w/ infect w/ w/ w/ vent support failur w/ procedur respiratori musculoskelet debrid w/ parasit diseas w/ circulatori treatment w/ post-traumat debrid skin failur w/ ventil support barclay servic
ltach select seen case mix increas averag
revenu per day increas select also success rebuilt
patient censu back pre-criteria level
concentra revenu
select own interest concentra largest provid occup health
servic unit state concentra oper medic center on-site clinic
employ worksit community-bas clinic state compani deliv
occup medicin consum health physic therapi veteran healthcar
servic site care employe worksit combin concentra/u
healthwork provid treatment workplac injuri
occup health servic includ worker compens injuri care well employ
servic clinic test well program prevent care util
compani occup medicin servic driven need labor-intens
industri gener pose higher risk injuri manufactur construct
revenuey/i medicar patient criteria beginallsem ltach criteria daili censusrevenu per daycas mix index barclay servic
transport goal occup medicin keep employe healthi
job get injur employe recov back job fast practic
half concentra revenu come worker compens plan
administ state-by-st basi gener worker compens plan
mandat law subject extens regul result manag worker
compens claim requir special experi navig variou regulatori
environ employ oper
concentra consum health servic includ non-employ patient-direct treatment
injuri ill via urgent care clinic prevent care
februari concentra acquir interest us healthwork second
largest provid occup medicin us valu us healthwork
seller digniti health maintain equiti interest combin concentra entiti us
expand concentra occup health busi nearli time acquisit
us healthwork footprint less overlap histor concentr
western us vs concentra histor concentr east combin compani
significantli expand reach manag expect realiz synergi drive cost save
total ebitda improv time period
pro-forma us healthwork acquisit own concentra welsh
carson digniti own rest minor partner put right
enabl sell stake back fair market valu one-third
exercis second anniversari transact year
compani present slide data
inpati rehabilit facil revenu
select inpati rehab facil irf provid comprehens physic medicin
rehabilit program optim patient health function qualiti life compani
current oper irf state
patient treat compani irf care need requir complex rehabilit
healthcar servic inpati set condit includ intens rehabilit
therapi complex brain spinal cord injuri stroke amput neurolog
disord orthopaed condit cancer averag length stay compani
irf patient day year-to-d select patient day paid
select seek partner lead healthcar system us use inpati
rehabilit basi comprehens rehab model addit inpati rehab
joint ventur often includ outpati rehab ltach occup medicin
compani significantli expand joint ventur irf strategi recent year
irf revenu grow past three year pipelin new facil remain
strong inpati rehab bed expect open next two year
repres growth licens irf bed
outpati rehab revenu
select outpati rehabilit segment largest oper outpati rehabilit
clinic us clinic across state nearli tripl number clinic
manag next closest competitor compani licens therapist provid
physic occup speech therapi program servic well variou
special rehabilit servic post-concuss rehab athlet train
servic patient seek rehabilit follow accid sport injuri work relat
injuri surgeri
market outpati rehab therapi includ private-practic local manag
own clinic hospit own affili clinic select outpati clinic
typic locat medic complex retail locat approxim revenu
outpati rehab segment commerci insur patient
select medic outpati rehabilit footprint
increas leverag acquir concentra earlier year close
us healthwork transact ltm net leverag ratio current stand ebitda
although expect leverag ratio continu declin next year
incom revenu administr stock equiti ebitda guidanc amort interest tax expens incom restrict incom avail common y/i barclay servic
balanc receiv net allow doubt current current equip intang asset portion long term debt note tax current term debt net current defer tax non-curr non-control liabil barclay servic
unconsolid bad earn unconsolid compens debt discount premium issuanc incom current payabl accru third activitiesacquisit busi net cash properti sale asset cash use invest activitiesdebt common paid exercis stock invest hold issuanc non-control non-control non-control cash provid financ increas decreas cash cash cash equival begin cash equival end barclay servic
inc quarterli annual ep usd
consensu number thomson reuter receiv gmt
initi coverag equal weight rate price target
health key strateg asset healthcar valu chain one two
remain pure play home healthcar provid scale health play pivot role
drive overal system cost industri continu evolv toward value-
base arrang increas risk take scale player abil
take risk primari beneficiari
strong platform growth past four year manag reshap
compani effici high-qual platform continu organ
acquisit growth compani realiz roughli ebitda
annual cost save past year simultan increas clinic
qualiti illustr averag home health star rate
year ago acquisit multipl home health space becom extend
expect compani continu focu build hospic platform
continu drive scale highli fragment hospic market underli market growth
well market share gain enabl compani drive home health volum
hospic volum high-singl digit rate next year
medicar uncertainti home health expect implement new home health
reimburs system industri dodg signific bullet year
cancel hhgm model passag budget neutral
requir new system new pdgm system still present risk
industri current expect implement behavior reduct base rate
addit move episod care believ industri
posit manag chang next two year new system
repres risk may temporarili dampen industri earn growth
price target base forward pe ratio forward
eb/ebitda premium rel compani histor trade rang given outsiz
growth opportun present next sever year
lead healthcar servic compani focuss provid care patient
home compani oper three segment home health hospic person care
revenu
ame home health segment provid care patient recov surgeri ill
live chronic diseas segment oper locat locat state
employ nurs provid wide array servic includ medic administr
wound care therapist provid physic speech occup therapi
home health aid assist patient variou person task
restructur busi manag return home health busi
growth year-to-d total same-stor admiss segment increas
margin increas perform repres rebound
disrupt compani face increas turnov among home health sale forc
follow chang made incent compens sinc time compani
backfil sale posit segment return organ volum growth
compani slow pace home health acquisit recent year part due
increas multipl seen marketplac part due desir continu
leverag hospic platform outperform recent year
hospiceperson ltm total incom ltm volumesnon-mdcr volumestot volumesy/i barclay servic
despit cmss rebas home health reimburs rate period
compani manag take cost busi leverag growth maintain
expand margin
hospic revenu
hospic care provid comfort support patient deal termin ill
patient termin ill heart diseas pulmonari diseas alzheim
hiv/aid cancer typic elig hospic care life expect
six month oper hospic center state
compani focuss build hospic footprint particularli market
strong presenc core home health busi hospic busi
synergist home health platform industri remain highli fragment
top ten player control market industri admiss grow
annual stabl reimburs outlook expect medicar price remain
rang next year
sinc reorgan busi compani driven outsiz volum growth
busi via strong organ growth averag organ volum margin
expand time period manag leverag volum across
platform
similar home health current acquisit multipl hospic marketplac also
becom extend compani still opportunist pursu acquisit
disciplin fashion howev also turn attent toward stand denovo
hospic locat first hospic denovo open earlier year manag
expect increas focu build denovo hospic locat
enter person care busi march acquisit
small oper massachusett activ expand footprint busi
sinc person care busi highli synergist home health busi
provid assist patient home activ daili live
person care segment meaning contributor revenu oper
incom point howev manag view offer import contract
manag care player increasingli want access full continuum home
certif need state current state restrict new entrant market home
health servic via certif need con requir con law provid barrier
entri market new competit provid competit advantag
incumb nearli home health locat within certif need con
state locat gener heavili weight toward southeast region
geograph footprint
statehomehospicepersonaltotalcertif need barclay servic
incom servic revenu margin gener administr expens misc tax effect tax net barclay servic
balanc receiv net bad current current equip asset long-term portion long-term current debt net current long-term sharehold liabil barclay servic
operationsnet compens tax incom doubt net receiv asset payabl cash provid oper properti equip defer comp asset cash use invest vest common issuanc net cash use financ cash begin end barclay servic
inc quarterli annual ep usd
consensu number thomson reuter receiv gmt
initi coverag equal weight rate price target
health key strateg asset healthcar valu chain follow acquisit
almost famili close earlier year lhc group one two remain pure
play home healthcar provid scale health play pivot role drive
overal system cost industri continu evolv toward value-bas arrang
increas risk take lhcg scale relationship partner hospit
enabl benefit movement toward risk-bas arrang post-acut care
addit opportun combin afam/lhc platform still come compani
complet transform merger almost famili april transact
nearli doubl size compani significantli expand geograph reach
locat reach senior unit state pre-
deal newli expand geograph footprint open access new pipelin
health system jv opportun continu propel growth across home health
hospic segment transact stock deal integr
aid outsid consult group leav combin compani ampl dri
powder deal team capac continu pursu typic smaller
acquisit jv opportun
medicar uncertainti home health expect implement new home health
reimburs system industri dodg signific bullet year
cancel propos hhgm model passag budget neutral
requir new system new pdgm system still present risk
industri current expect implement behavior reduct base rate
addit move episod care believ would
like abl manag headwind next two year new system
repres risk may temporarili dampen industri growth
price target base forward pe ratio
ev/ebitda repres premium histor trade rang given growth
opportun next sever year
lead healthcare-servic compani focuss provid care patient
home major compani revenu ebitda gener
home health segment enter first joint ventur hospit twenti
year ago compani industri leader partner hospit health
system across countri
compani focuss growth core market aggress pursu market
share organ growth driven high qualiti patient satisfact experi
market select compani long develop cultur sale strategi
lhc focuss creat joint ventur partnership local hospit system
typic seek share jv compani creat first home health jv
hospit partner current joint ventur cover hospit
partner repres consolid revenu jv strategi enabl
becom prefer in-hom healthcar provid hospit partner creat reliabl
lhc jv locat typic brand hospit name employe
employe lhc wear brand hospit system lhc enabl lhc
benefit strong local brand recognit hospit system often highli
regard local commun hospit increasingli ask take risk
form bundl payment value-bas arrang lhcg posit
post-acut jv partner also make compani natur partner hospit system
come post-acut value-bas arrang current jv partner includ baptist
health system christu health lifepoint health
hospic base ltm incom ltm repres annual patient dayswholli own ventur revenu barclay servic
seek grow via acquisit typic look acquir smaller
compani desir market per year compani long success track record
acquir grow new locat compani expect add acquir
revenu per year includ acquir home health asset new hospit jv partner
april lhc group complet merger almost famili afam
stock merger equal transact nearli doubl size compani creat
third largest platform home health industri
two compani littl geograph overlap counti counti
overlap result combin compani significantli increas nation
reach scale pre-merg geograph coverag
popul addit afam combin compani reach
popul particularli signific gain import florida market
transact accret earn within first year compani
indentifi corpor cost synergi date manag expect drive
addit top line growth combin compani enter new jv
expand geographi increas complementari servic offer within exist
branch expect compani continu identifi synergi beyond initi
indentifi integr continu includ benefit realiz
integr afam lhcg custom homecar homebas platform
expect drive increment cost save next two year
health segment revenu
lhcg home health segment provid skill nurs physic occup speech
therapi medic social servic patient recov surgeri ill live
chronic diseas segment oper locat whole-own
major own equiti joint ventur
provid compani employ nurs therapist provid wide
array servic includ wound care cardiac rehabilit infus therapi physic
speech occup therapi medic administr
compani jv strategi uniqu home health marketplac enabl
compani continu close deal reason valuat despit recent expans
multipl seen marketplac
lhc group home health revenu medicar fee-for-servic
despit cmss rebas home health reimburs rate period
compani manag expand patient popul serv take cost
busi maintain expand margin
hospic revenu
lhc group hospic segment provid end-of-lif care patient termin ill
team physician nurs home health aid counsel volunt servic
provid includ pain symptom manag emot spiritu support inpati
respit care homemak servic counsel compani oper locat
own via compani hospit health system joint-ventur
oper nearli locat cover approxim us popul
age
incom servic margin administr y/i y/i expens oper tax effect tax net barclay servic
balanc receiv net bad current current equip asset long-term portion long-term insur expens current current debt net current long-term sharehold liabil barclay servic
operationsnet compens tax doubt net receiv asset payabl cash provid oper properti equip payment cash use invest tax benefit stock common stock includ fee exercis stock warrants/stock purchas paid non-controlling interest consolid net cash use financ cash cash cash equival begin period cash equival end barclay servic
equal weight home health set
industri head long term
expect home health provid continu
captur market share higher-cost set
skill nurs facil expect scale player
believ opportun price
potenti headwind new medicar pdgm
model mitig via either legisl compani
oper chang growth acceler drive
earn estim higher addit
multipl expans forward earn
new medicar pdgm model implement
disrupt industri current
expect drive revis ep estim
use forward multipl lower
ep would drive downsid case
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
differenti dialysi model exclus focus
joint ventur partnership nephrologist see
denovo jv model ara smaller base clinic
drive treatment growth rang
next year expect recent slowdown
denovo ramp persist howev
growth denovo ramp rebound faster
expect commerci price pressur
diminish result revis ebitda
estim multipl expans forward
denovo growth slow commerci mix
pressur drive flat y/i ebitda forward
ebitda multipl contract
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight like risk/reward head
particularli given expect
sale dmg expect materi share
repo next year pro-forma dmg sale
share trade signific discount
histor trade rang
estim revis higher multipl
expand ebitda
commerci mix pressur increas drive mix
increment result revis
ebitda estim proce sale dmg
less expect result lower share repo
forward ebitda multipl contract
pro-forma sale
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
equal weight encompass lead
inpati rehabilit facil irf platform
industri smaller fast grow home health
platform continu benefit
develop program think share fulli
discount opportun point
growth acceler due faster expect
denovo open ramp result
revis higher ebitda health
reimburs chang success mitig
dampen earn growth forward
multipl expand
health reimburs chang
oner expect lead ebitda
reduct home health segment irf denovo
growth slower expect result multipl
contract
equal weight home health set
industri head long-term
expect home health provid continu
captur market share higher cost set
skill nurs facil expect scale player
believ opportun price
potenti headwind new medicar pdgm
model mitig via either congression action
increas oper effici growth
acceler drive upsid estim
multipl expand
new medicar pdgm model implement
disrupt industri current
expect earn estim revis
chang forward multipl
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
equal weight select medic irf platform
produc strong growth via jv strategi
revenu howev view
major busi segment low-singl digit
compani abl push ltach occup
near term us
healthwork margin improv faster expect
drive forward ebitda estim higher
chang forward multipl
irf denovo ramp slower expect ltach
occup stall current level drive forward
ebitda estim lower multipl
contract
valuat methodolog risk
valuat methodolog price target base forward pe ratio ep estim
ev/ebitda premium rel compani histor trade rang given outsiz growth opportun next sever year
risk may imped achiev barclay research valuat price compani heavili depend
medicar reimburs rate signific portion revenu earn rate could lower expect futur
process implement new home health reimburs system could result lower revenu earn
compani unabl success mitig chang
compani unabl success execut develop strategi growth could stall result lower expect forward
valuat methodolog price target assum stock trade ebitda-nci premium
dialysi peer given strong long-term growth outlook
risk may imped achiev barclay research valuat price commerci price mix headwind could
result ebitda growth less expect
slower ramp new clinic growth could result slower ebitda growth
compani heavili depend medicar reimburs rate could less expect
valuat methodolog price target assum stock trade ebitda-nci estim
ev/ebitda pro-forma dmg sale repres turn discount dva histor trade multipl given risk
risk may imped achiev barclay research valuat price commerci price mix headwind may
expect result lower ebitda growth
compani heavili depend medicar reimburs rate could lower expect
treatment volum growth could less expect
valuat methodolog price target base multipl ev/ebitda-nci estim premium
histor trade rang given stronger ebitda growth outlook next sever year
risk may imped achiev barclay research valuat price compani heavili depend
medicar reimburs rate could lower expect futur result slower expect ebitda growth
expect implement new home health reimburs model could result lower revenu margin
compani unsuccess mitig chang
volum growth could slow compani unabl execut denovo facil growth plan opportun new facil
valuat methodolog price target base pe ratio appli estim ev/ebitda
repres premium histor trade rang given growth opportun next sever year
risk may imped achiev barclay research valuat price compani heavili depend
medicar reimburs rate signific portion revenu earn rate could lower expect futur
process implement new home health reimburs system could result lower revenu earn
compani unabl success mitig chang
compani unabl success execut develop strategi growth could stall result lower expect forward
compani process integr transform merger almost famili creat possibl disrupt
valuat methodolog price target assum stock trade forward ebitda-nci estim
ebitda line compani histor trade rang
risk may imped achiev barclay research valuat price compani deriv signific amount
revenu medicar program reimburs rate less expect estim could high
compani fail execut inpati rehabilit develop strategi opportun partnership health system
diminish earn growth could lower expect
sem concentra segment process integr us healthwork acquisit integr could face unexpect challeng
result lower expect profit segment
patrick feeley steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli
indirectli relat specif recommend view express research report
